Steven Rosenberg
 | This poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. )Find sources: "Steven Rosenberg" – news · newspapers · books · scholar · JSTOR (February 2013) |
Steven Rosenberg | |
|---|---|
erythrocyte membranes (1969) |
Steven A. Rosenberg (born 2 August 1940humans.
Early life
Rosenberg was born in 1940, in the
Peter Bent Brigham Hospital, who was the chief nurse at the time. They got married in 1968 and have three daughters.[1]
Methodology
He is credited with developing the use of
GM-CSF, had been used many years previously and continue to be used, although the efficacy of GM-CSF modified tumor lines as a cancer vaccine remain extremely modest, at best.[6]
There has been some debate as to the role of the T cells in treating the cancer in these studies as high-dose IL-2 and chemotherapy have also been shown to have anti-cancer properties. Nevertheless, the combination of chemotherapy, T cells and high-dose IL-2 was shown to be effective even in patients who had previously failed high-dose IL-2 treatment.
Rosenberg has pioneered the use of adoptive immunotherapy.
Education
Rosenberg graduated from the Bronx High School of Science. He received his
immunotherapy of cancer
.
Awards and honors
- 1992 Golden Plate Award of the American Academy of Achievement[7]
- 2011 William B. Coley Award for Distinguished Research in Tumor Immunology of the Cancer Research Institute
- 2013 Keio Medical Science Prize
- 2015 Medal of Honor of the American Cancer Society
- 2018 Albany Medical Center Prize in Medicine and Biomedical Research [8]
- 2019 Edogawa NICHE Prize[9]
- 2019 Szent-Györgyi Prize for Progress in Cancer Research[10]
- 2021 Dan David Prize[11]
- 2022 Pezcoller Foundation-AACR International Award for Extraordinary Achievements in Cancer Research
- 2023 Clarivate Citation Laureates[12]
- 2023 National Medal of Technology and Innovation[13]
See also
- Cell therapy
- Chimeric antigen receptor
- Immunotherapy
- Iovance Biotherapeutics
References
- ^ a b c d e f "Steven A. Rosenberg Works to Unmask Cancer's Achilles Heel - the ASCO Post".
- ^ Pollack, Andrew (August 1, 2016). "Setting the Body's 'Serial Killers' Loose on Cancer (Published 2016)". The New York Times.
- PMID 29443657.
- PMID 12242449.
- PMID 16946036.
- PMID 11134207.
- American Academy of Achievement.
- ^ "Trailblazing Researchers in Immunotherapy Selected to Receive Americas Most Distinguished Prize in Medicine". www.amc.edu.
- ^ "2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy". www.marketscreener.com. 15 August 2019.
- ^ "Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research". National Foundation for Cancer Research. 12 February 2019. Retrieved 24 February 2021.
- ^ Dan David Prize 2021
- ^ "Citation Laureates 2023_Physiology or Medicine". Citation Laureates. Clarivate. Archived from the original on September 19, 2023. Retrieved September 19, 2023.
- ^ "NIH immunotherapy pioneer Steven Rosenberg awarded nation's highest honor for technology and innovation". National Institutes of Health (NIH). 2023-10-24. Retrieved 2023-10-24.
External links
- Gene therapy rids men of cancer, BBC News (2006 coverage of cancer breakthrough discovered by his team)
- "Cancer Miracles", Robert Langreth, Forbes, 2009
